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Crystallization of a designed peptide from a molten globule
ensemble
Stephen F Betz1, Daniel P Raleigh1†, William F DeGrado1, Brett Lovejoy2‡,
Daniel Anderson2, Nancy Ogihara2 and David Eisenberg2
Background: The design of amino acid sequences that adopt a desired three-
dimensional fold has been of keen interest over the past decade. However, the
design of proteins that adopt unique conformations is still a considerable
problem. Until very recently, all of the designed proteins that have been
extensively characterized possess the hallmarks of the molten globular state.
Molten globular intermediates have been observed in both equilibrium and kinetic
protein folding/stability studies, and understanding the forces that determine
compact non-native states is critical for a comprehensive understanding of
proteins. This paper describes the solution and early solid state characterization
of peptides that form molten globular ensembles.
Results & Conclusions: Crystals diffracting to 3.5 Å resolution have been
grown of a 16-residue peptide (1A) designed to form a tetramer of -helices. In
addition, a closely related peptide, 1, has previously been shown to yield
crystals that diffract to 1.2 Å resolution. The solution properties of these two
peptides were examined to determine whether their well defined crystalline
conformations were retained in solution. On the basis of an examination of their
NMR spectra, sedimentation equilibria, thermal unfolding, and ANS binding, it is
concluded that the peptides form -helical aggregates with properties similar to
those of the molten globule state. Thus, for these peptides, the process of
crystallization bears many similarities to models of protein folding. Upon
dissolution, the peptides rapidly assume compact molten globular states similar
to the molten globule like intermediates that are formed at short times after
refolding is initiated. Following a rate-determining nucleation step, the peptides
crystallize into a single or a small number of conformations in a process that
mimics the formation of native structure in proteins.
Introduction
The effective design of amino acid sequences that adopt a
desired three-dimensional fold has progressed over the
past decade [1,2]. Whereas the majority of early design
efforts focused on -helical bundles [3,4], recent designs
have focused on -sheet proteins [5,6] and mixed –
proteins [7–10]. Yet these proteins, and most other
designed proteins that have been well characterized in
solution, possess some of the properties of the ‘molten
globular’ state [11]. Used here, the term ‘molten globule’
refers to a compact state that possesses a high degree of
secondary structure, but a more dynamic hydrophobic
interior [12–15]. On the other hand, the design of pep-
tides that mimic various aspects of protein structure has
been more successful [16–20]. Peptides that adopt -turns
[16], monomeric helices [19], and helix-turn-helix hair-
pins [21,22] have been designed and their structures
determined by NMR and X-ray crystallography. In addi-
tion, a helix-turn-helix peptide that self-assembles into a
native-like four-helix structure has been reported [23,24],
as has the self-assembly of a heterotrimeric -helical
complex [25].
The work described in this paper continues the thread of
peptide and protein design that has focused on the
design, construction, and crystallographic characterization
of -helical peptides that self-assemble into protein-like
structures [26,27]. One class of peptides that has been
extensively characterized [28–30] is a family of 12–16-
residue amphiphilic -helices, the prototype of which is
1A (see Fig. 1). This 16-residue peptide contains leucine
residues arranged along one face of the helix to form sta-
bilizing helix–helix hydrophobic interactions. The oppo-
site face of the helix consists of glutamine and lysine
residues that electrostatically stabilize the structure and
provide aqueous solubility. During the synthesis of 1A, a
12-residue fragment of the desired sequence was isolated
(designated 1), and its crystal structure determined at
low pH [26]. As in the design, the structure consists of a
hydrophobically stabilized cluster of -helices. However,
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the primary association in the crystal was a hexameric
molecule. This unusual arrangement of helices may have
been favored by the short length of the 1 peptide as well
as the low pH at which the peptide was crystallized. At
neutral pH, the peptide crystallizes into an entirely dif-
ferent helical assembly featuring a tetramer in the asym-
metric unit [31]. This finding prompted us to question
whether the distinct structures of the peptide arose from
different but stable aggregation states at low pH versus
neutral pH, or whether it was a dynamic ensemble in
solution.
We have also renewed our efforts to characterize the full-
length 1A peptide, both in aqueous solution and in the
solid state. We find that although this peptide shows the
hallmarks of a molten globule in solution, it nevertheless
yields diffraction-quality crystals. It was unexpected that
1A would form high-quality crystals because a closely
related peptide, 1B, had previously been shown to form
molten globule like tetramers in solution [30], and crystal-
lization efforts with 1B have thus far been unsuccessful.
Investigation of the solution properties of 1A allows us to
determine whether this peptide is more ordered than 1B,
or whether diffraction-quality crystals had indeed grown
from a molten globule ensemble of conformational states.
Results
Crystallization and solid state association
The 1A peptide was crystallized at neutral pH and
ambient temperature yielding trigonal crystalline rods. If
there is a peptide dimer in the asymmetric unit and a
space group of P321 (see Materials and methods), a four-
-helical bundle is formed at the interface of two neigh-
boring asymmetric units. The crystals of 1A are like those
of globular proteins, although they appear less well
ordered as indicated by their high mosaic spread (1.2°).
Solution state association
The partial specific volumes and the solution oligomeriza-
tion states of the 1 and 1A peptides were determined
under neutral conditions as described in Materials and
methods. The initial concentration of peptide in the sedi-
mentation equilibria experiments was approximately
2 mM where both peptides are fully associated [28]. At
neutral pH, 1A was best fit as a single species to a molec-
ular mass of 7242–7762 Da, corresponding to an aggrega-
tion state of 3.9–4.1 (Fig. 2), consistent with earlier data
showing that 1A assumed a highly cooperative
monomer/tetramer equilibrium [28]. No intermediate
states could be discerned, although the small molecular
mass of the monomer (1883 Da) coupled to our limitation
in highest available rotor speed (48000 rpm) and the rela-
tively high initial peptide concentration made accurate
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Figure 2
Sedimentation equilibrium of 1A.
Absorbance at 245 nm versus radius for raw
data (squares) and different theoretical
monomer/nmer fits for 2 mM 1A in 50 mM
MOPS pH 7.0, 298 K, at 48 000 rpm. Dot-
dashed line, fit to trimer; Solid line, fit to
tetramer; Dashed line, fit to pentamer; Dotted
line, fit to hexamer.
Figure 1









determination of Kd difficult. Under these conditions, the
concentration of the associated species far exceeds that of
the monomer (the midpoint of the association equilibrium
is approximately 35 µM). Nevertheless, the determined
value (Kd ~10–13 M3) is in reasonable agreement with the
value of 2 ×10–14 M3 determined by Ho and DeGrado [28]
under slightly different conditions. Thus, at accessible
experimental conditions, 1A is almost fully tetrameric.
In contrast to the well defined aggregation behavior
observed for 1A, the predominant aggregation state of
the shorter 1 peptide depended on the concentration of
the peptide. The sedimentation data were fitted to coop-
erative monomer/n-mer aggregation schemes. At an
initial loading concentration of 400 M, the sedimenta-
tion data were best described by a monomer/pentamer
equilibrium, in reasonable agreement with earlier con-
centration-dependent circular dichroism (CD) experi-
ments under comparable conditions, which showed a
cooperativity of four. As the concentration is further
increased, however, higher order aggregates are formed.
At an initial loading concentration of 2 mM, the data are
best fit to an aggregation state of 8.0. The CD and sedi-
mentation equilibrium data together suggests a complex
association, with the minimal stable association state of
1 approximately four. However, this aggregate can non-
cooperatively associate further to form higher order
aggregates. This second process was not apparent in
earlier CD experiments [17] presumably because it does
not involve a change in secondary structure content. The
formation of higher aggregates was readily apparent in
the sedimentation studies, though, because the buoyant
molecular weight changes as the aggregation state
changes. These results illustrate the complementarity of
these two methods for measuring both the minimal
stable association state and the actual association at a
given concentration.
Circular dichroism
The concentration-dependent thermal denaturation of 1A
monitored at 222 nm is shown in Figure 3. At high concen-
trations, non-cooperative gradual unfolding is observed
with increasing temperature. To determine whether this
behavior is a consequence of an extremely stable tetramer,
or simply low values of H and Cp, the experiment was
also carried out near the midpoint of the concentration-
dependent transition where temperature-dependent
changes in association should be readily observed. At
20 µM, broad sigmoidal denaturation curves are observed,
indicating that the unfolding occurs with low values of H
and Cp, as is frequently observed for molten globules
[15,32,33]. In short, thermal denaturation of 1A suggests
that the tetramer behaves more like previously character-
ized molten globules than native-like proteins.
NMR solution behavior
The one-dimensional NMR spectra of 1A at 20°C and
pH 5.5 is shown in Figure 4. The amide proton region is
reasonably well dispersed and two-dimensional NOESY
spectra show a series of NHi to NHi+1 crosspeaks
(DP Raleigh, unpublished data). Both these observations
are consistent with a well defined -helical conformation.
Similar observations have been made for the 1 [29] and
1B peptides [30]. The methyl resonances are poorly
defined at both pH values. This lack of dispersion is partly
due to the absence of aromatic moieties, but it also sug-
gests that there is rapid averaging of the core on the NMR
time scale. Therefore, the secondary structure of 1A
appears well defined, whereas the conformations of the
interior sidechains are not.
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Figure 3
Mean residue ellipticity at 222 nm versus
temperature for 1A in 50 mM MOPS, pH 6.6.
Sample concentrations were 2 mM (circles),
200 µM (squares), and 20 µM (triangles).
ANS-binding studies
The binding of 8-anilino-1-naphthalenesulfonic acid
(ANS) to 1A was investigated. ANS is a hydrophobic dye
that exhibits a large increase in fluorescence intensity
when in an apolar environment. Experimental evidence
correlates the binding of this dye with molten globular
behavior [12–14,34]. The emission spectrum of ANS in
the presence of 1A depends markedly on the concentra-
tion of the peptide (see Fig. 5a). At concentrations below
the midpoint of association of the peptide, little binding is
observed, but at higher concentrations a large change in
intensity and emission maximum is observed. At peptide
concentrations at which most of the ANS is bound, the
emission maximum of ANS bound to 1A is 462 nm, com-
pared to 454–472 nm for ANS bound to protein molten
globules under similar conditions [14]. Similar results
were observed for the 1 peptide. At low concentrations,
no change in the fluorescence spectrum was observed, but
at concentrations at which the peptide was aggregated an
increase in quantum yield and a blue shift of the emission
maximum were observed. At neutral pH, the emission
maximum was shifted to 466 nm. Near pH 3, the
quantum yield was further increased and the emission
maximum shifted to 461 nm (see Fig. 5b). Thus, ANS-
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Figure 4
One-dimensional 1H NMR spectra for 1A in
water at 20°C, pH 5.5. (a) Amide region. (b)
Aliphatic region. Sample concentration was
4 mM.
binding suggests a molten globule like character for both
1 and 1A.
Discussion
The solution characteristics of 1 and 1A
Extensive solution measurements of 1 have previously
shown [17,29] that this peptide associates into oligomers in
which the monomers assume well ordered, -helical back-
bone conformations. However, these aggregates are not as
well ordered as in native proteins. A variety of association
states are observed, depending on the peptide concentra-
tion, and the monomers are in rapid equilibrium with the
associated form on the millisecond time scale [29], indicat-
ing that there is a small activation energy for the associa-
tion/dissociation of these peptides. There is very little
dispersion of the sidechain resonances of this peptide, and
it also binds ANS. Both of these features suggest that the
oligomers have poorly ordered interior sidechains.
The properties of 1A parallel those of 1 in many regards.
The lack of dispersion in the sidechain region of the NMR
spectrum, the binding of ANS, and the lack of a well
defined thermal unfolding transition collectively provide
strong evidence for a molten globule like ensemble. One
difference, however, is that 1A very cooperatively assem-
bles into a single, tetrameric aggregation state. Yet,
despite its dynamic properties, 1A is able to form diffrac-
tion quality crystals; similarly, 1 crystallizes in an
extremely well ordered state capable of diffraction of X-
rays beyond 1 Å.
Crystallization as a mimic of protein folding
The fact that 1 and 1A form diffraction-quality crystals
suggests that they are capable of assuming particular con-
formations that are stable enough to nucleate crystalliza-
tion. Thus, the process of crystallization of these
peptides bears many similarities to models of protein
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Figure 5
ANS-binding of 1 and 1A. (a) Fluorescence
emission spectra of ANS alone (open,
inverted triangles), and in the presence of
10 µM 1A (closed circles), and 60 µM 1A
(closed squares) in 20 mM MES pH 6.5. (b)
Fluorescence emission spectra of ANS alone
(open, inverted triangles), and in the presence
of 2 mM 1A in 20 mM MES pH 6.2 (open
circles), and 2 mM 1 in 20 mM MES pH 6.5
(open triangles), and 2 mM 1 in 20 mM
NaOAc pH 3.3 (open squares).
folding that involve molten globule like intermediates:
upon dissolution in water, the peptide rapidly assumes a
compact globular structure consisting of an ensemble of
interconverting conformational states. Following nucle-
ation, the peptide crystallizes in a single (or small
number of) conformation(s). Proteins are often hypothe-
sized to adopt their unique, folded conformations by
mechanisms that involve formation of molten globular
intermediates [35]. The essential difference between
these designed proteins and naturally occurring ones is
that a natural protein contains sufficient information in
its sequence to specify a unique conformation, whereas
crystal packing forces are necessary to order the confor-
mations of 1 and 1A (Fig. 6). The two designed pro-
teins described here differ in that 1A is able to form a
meta-stable structure in solution, whereas 1 indiscrimi-
nately associates with increasing concentration. Crystal
packing forces seem nearly totally responsible for the
structure of 1 (i.e. the energy difference between the
native solution ensemble [N] and crystalline [C] states is
large), but appear less so, and more akin to the final
stages of protein folding, in the formation of the 1A
structure.
A final conclusion of this study is that because of their
dynamic properties, designed peptides and proteins may
have different structural characteristics in solution and in
the solid state. Thus, it is more important with designed
proteins than natural proteins to examine thoroughly the
solution properties prior to concluding that the crystallo-
graphically determined structure represents the full con-
formational properties in solution.
Materials and methods
Peptide synthesis and purification
The peptide was synthesized by standard automated methods on a Mil-
ligen 9050 and purified by reverse phase HPLC. Specifically, using a
loading volume of 1 ml of 10 mg ml–1 crude peptide, pure 1A was col-
lected after 16.5 min during a 20-min gradient from 10–75% CH3CN
in the presence of 0.05% TFA on a 25 mm × 200 mm Radial-Pak
preparative µBondpak C18 column (Waters) with a flow rate of
15.7 ml min–1.
Crystallization conditions
Crystals of 1A were grown by the sitting drop method. Drops were
prepared by mixing 12 µl of a 20 mg ml–1 solution and 12 µl of a reser-
voir solution that consisted of a 25 mM imidazole buffer adjusted to
pH 7.0 with HCl, 23% (w/v) polyethylene glycol-8000 and 14.3% (v/v)
ethanol. Crystalline rods measuring 1.0×0.2 ×0.1 mm grew within 11 d
of incubation at 22°C. Crystallization at 4°C and 30°C had no signifi-
cant effect on crystal size.
Space group determination
To determine the space group of 1A, data to 5 Å resolution were col-
lected on a single crystal using an AFC5R diffractometer (Rigaku).
Data reduction using MSC software (Molecular Structure Corporation)
indicated that the crystals belonged either to the trigonal/rhombohe-
dral or hexagonal crystal systems. The cell parameters are
a = b = 51.0 Å, c = 23.9 Å,  =  = 90° and  = 120°. Further analy-
sis of the data set revealed that one rule for six-fold symmetry
[F(h-kl)] = [F(hk-l)] is not obeyed, thus eliminating all hexagonal space
groups. The rhombohedral space groups R3 and R32 were also ruled
out by of the presence of –h + k + l′ ≠ 3n reflections (hexagonal index-
ing). Analysis of the data also revealed the presence of a two-fold axis
half-way between a* and b*, thus limiting the possible space groups to
P3x21 (where x is 0, 1, or 2). The finding that reflections l ≠ 3n along
the 00l line were present in the data indicated that the space group is
P321. Based on this space group and a molecular mass of 1883 Da
per monomer, there is either a peptide trimer or peptide dimer in the
asymmetric unit (corresponding respectively to Vm = 1.59 or
2.38 Å3 Da–1) ADDIN [36]. A peptide monomer in the asymmetric unit
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Figure 6
Hypothetical energy relationship for the
folding and crystallization of a natural protein
and designed proteins like 1 and 1A. The
bars symbolize the number of energy states
populated in each regime. The highest bar (or
dashed bar) represents the upper limit of kT.
The denatured state (D) is represented by a
large number of conformations. Whereas a
natural protein has a well defined native state
(N) in solution, the designed protein exists as
an ensemble with many nearly equivalent
energetic states, similar to proposed
intermediates (I) in the folding of naturally
occuring proteins. In the crystalline state (C),
both have defined structures, although for the
case of 1A, the limited resolution and high
mosaic spread of its crystals suggest that they
are composed of more substates than the
most well ordered protein crystals.
is highly unlikely because the corresponding Matthews number,
Vm = 4.77 Å3 Da–1, exceeds the 1.68–3.53 Å3 Da–1 range that is typi-
cally observed for protein crystals [36].
Analytical ultracentrifugation
Sedimentation equilibrium analysis was performed with a Beckman
XLA analytical ultracentrifuge. Initial peptide concentrations were
2–4 mg ml–1 in 50 mM MOPS, pH 7.0 or 50 mM NaOAc, pH 3.3. High
concentrations were chosen so that the peptides would be nearly fully
associated in solution. The samples were centrifuged at 35 000,
42 000, and 48 000 rpm. Equilibrium was determined when successive
radial scans at the same speed were indistinguishable.
The behavior of a single species at equilibrium can be described by the
following equation:
Mb = Mw (1– v
–) (1)
in which Mb is the measured buoyant molecular mass, Mw is the mole-
cular mass in Daltons, v– is the partial specific volume of the protein,
and  is the density of the sample solution. Accurate determination
requires that both the density and partial specific volume be known.
The densities of the solutions were measured with an Anton–Paar
DMA–602 external measuring cell using a sampling frequency of
2 kHz. Determinations were made under the same conditions as the
sedimentation experiments. The aggregation state was determined by
fitting the data to either a single monomeric species or by
monomer/nmer equilibria, using the software package Igor Pro
(WaveMetrics). Radial absorbance spectra were recorded at several
appropriate wavelengths and were shown to yield indistinguishable
results.
The determination of association of a species also requires that the
partial specific volume, v–, be accurately known. Using a method based
on residue composition [37,38], the calculated v– for 1A is 0.78 ml g–1,
and the calculated v– for 1 is 0.80 ml g–1 These values are somewhat
higher than those measured for typical globular proteins,
0.70–0.75 ml g–1 [39]. As a result of their minimalist design, their asso-
ciative character, and their atypical amino acid composition compared
with naturally occurring proteins, the values of v– calculated by residue
composition alone may not reflect their true values when associated in
solution. The partial specific volumes of 1 and 1A were measured
experimentally from simultaneous determination of its buoyant molecu-
lar mass in H2O and D2O-based buffer systems [40]. The partial spe-
cific volume of 1A determined by this method was 0.75 ml g–1, and
that of 1 was determined to be 0.77 ml g–1. As a control, the partial
specific volume of horseheart cytochrome c (Sigma) was determined to
be 0.72 ml g–1 by the same method, in close agreement with the value
of 0.725 ml g–1 reported by Gekko & Hasegawa [39].
NMR spectroscopy
1H NMR spectra were recorded with a Bruker AMX-600 spectrometer
at 20°C using presaturation of the water resonance. One-dimensional
spectra were recorded with 8K points. The raw data were transformed
and phased using Felix 2.2 software (Hare/Biosym).
Fluorescence measurements
Fluorescence of ANS–peptide complexes were performed on a Spex
Fluorolog fluorimeter at 25°C. The formation of ANS peptide com-
plexes was monitored by titrating peptide into a constant amount
(5 µM) of ANS in a 1 cm cuvette. Buffer conditions were 20 mM MES,
pH 6.5. The excitation wavelength was 370 nm with emission spectra
recorded from 420–500 nm.
Circular dichroism
The circular dichroism of peptide solutions was monitored with an AVIV
62 DS spectropolarimeter interfaced to an IBM PC. Buffer conditions
were 50 mM MOPS, pH 6.6, or 50 mM sodium acetate, pH 3.3. The
concentration of peptide for the CD experiments ranged from 20 µM to
1 mM. Mean residue ellipticities (° cm2 dmol–1) were calculated using
the equation:
[222]=(obsd/10lc)/n (2)
in which obsd is the ellipticity measured in millidegrees, l is the length
of the cell in cm, c is the peptide concentration in mol l–1, and n is the
number of residues.
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